About Midostaurin Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic…
About Dasatinib Dasatinib is a targeted therapy medication used to treat certain cases of chronic myelogenous…
About Dasatinib Dasatinib is a targeted therapy medication used to treat certain cases of chronic myelogenous…
About Dasatinib Dasatinib is a targeted therapy medication used to treat certain cases of chronic myelogenous…
About Ponatinib Ponatinib is a medication used for the treatment of chronic myeloid leukemia and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia. It…
About Ponatinib Ponatinib is a medication used for the treatment of chronic myeloid leukemia and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia. It…
Ivosidenib is a first-in-class isocitrate dehydrogenase-1 (IDH1) inhibitor. Ivosidenib is an anti-cancer medication for the treatment of acute…
Olverembatinib is a small-molecule, oral BCR-ABL1 TKI that works by inhibiting the BCR-ABL1 kinase at the…
Orelabrutinib is a novel, highly selective, irreversible BTK inhibitor with high target selectivity and safety. Orelabrutinib sold…
Gilteritinib is a small molecule part of the FLT3 tyrosine kinase inhibitors that presented a greater…
Brand name: Ventop. Generic name: Venetoclax [Indications] Venetoclax is a bcl-2 inhibitor for the treatment of…
About Enasidenib Enasidenib is a medication used to treat relapsed or refractory acute myeloid leukemia (AML) in people with…
About Asciminib Asciminib is a medication used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Asciminib is a protein kinase inhibitor. Chronic Myeloid…
About Quizartinib Quizartinib is an anti-cancer medication used for the treatment of acute myeloid leukemia. It is a small molecule receptor…
About Ponatinib Ponatinib is a medication used for the treatment of chronic myeloid leukemia and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia. It…
Ivosidenib is a first-in-class isocitrate dehydrogenase-1 (IDH1) inhibitor. Ivosidenib is an anti-cancer medication for the treatment of acute…
Copyright © 2021-2022 LienTeh.net All rights reserved.
